JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lacey, M. G.
Right arrow Articles by North, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lacey, M. G.
Right arrow Articles by North, R. A.

Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors

MG Lacey, P Calabresi and RA North

Vollum Institute, Oregon Health Sciences University, Portland.

Intracellular recordings were made from presumed dopamine-containing neurons in slices of rat mesencephalon. Muscarine (3-100 microM) increased the rate of spontaneous action potentials; it also caused a membrane depolarization and, in voltage-clamp, an inward current. Concentration-effect curves to muscarine were shifted rightwards by pirenzepine (0.03-1 microM) with an estimated KD of 14 nM. The inward current caused by muscarine was voltage-dependent. Between about -50 and (-)-65 mV it was associated with a decrease in membrane conductance, but between -70 and -110 mV it was unaccompanied by any change in membrane conductance. Muscarine was without effect on the action potential afterhyperpolarization, or on a slowly developing inward current evoked by step hyperpolarizations of up to 20 mV from - 45 mV. Muscarinic depolarizations or inward currents were reduced reversibly or abolished by a low calcium (0.25 mM)/high magnesium (10 mM) solution. It is concluded that muscarinic excitation of dopaminergic neurons is mediated by M1-like receptors.

Volume 253, Issue 1, pp. 395-400, 04/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
S. N. Blythe, J. F. Atherton, and M. D. Bevan
Synaptic Activation of Dendritic AMPA and NMDA Receptors Generates Transient High-Frequency Firing in Substantia Nigra Dopamine Neurons In Vitro
J Neurophysiol, April 1, 2007; 97(4): 2837 - 2850.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
S. Koyama and S. B. Appel
Characterization of M-Current in Ventral Tegmental Area Dopamine Neurons
J Neurophysiol, August 1, 2006; 96(2): 535 - 543.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. Zhang, Y. Liu, and X. Chen
Carbachol induces burst firing of dopamine cells in the ventral tegmental area by promoting calcium entry through L-type channels in the rat
J. Physiol., October 15, 2005; 568(2): 469 - 481.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
F.-M. Zhou, C. Wilson, and J. A. Dani
Muscarinic and Nicotinic Cholinergic Mechanisms in the Mesostriatal Dopamine Systems
Neuroscientist, February 1, 2003; 9(1): 23 - 36.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
S. Ikemoto and R. A. Wise
Rewarding Effects of the Cholinergic Agents Carbachol and Neostigmine in the Posterior Ventral Tegmental Area
J. Neurosci., November 15, 2002; 22(22): 9895 - 9904.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. S. Basile, I. Fedorova, A. Zapata, X. Liu, T. Shippenberg, A. Duttaroy, M. Yamada, and J. Wess
Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia
PNAS, August 20, 2002; 99(17): 11452 - 11457.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
R. S. Scroggs, C. G. Cardenas, J. A. Whittaker, and S. T. Kitai
Muscarine Reduces Calcium-Dependent Electrical Activity in Substantia Nigra Dopaminergic Neurons
J Neurophysiol, December 1, 2001; 86(6): 2966 - 2972.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. S. Yeomans, J. Takeuchi, M. Baptista, D. D. Flynn, K. Lepik, J. Nobrega, J. Fulton, and M. R. Ralph
Brain-Stimulation Reward Thresholds Raised by an Antisense Oligonucleotide for the M5 Muscarinic Receptor Infused near Dopamine Cells
J. Neurosci., December 1, 2000; 20(23): 8861 - 8867.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. D. Fiorillo and J. T. Williams
Cholinergic Inhibition of Ventral Midbrain Dopamine Neurons
J. Neurosci., October 15, 2000; 20(20): 7855 - 7860.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B.H.C. Westerink, P. Enrico, J. Feimann, and J.B. De Vries
The Pharmacology of Mesocortical Dopamine Neurons: A Dual-Probe Microdialysis Study in the Ventral Tegmental Area and Prefrontal Cortex of the Rat Brain
J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 143 - 154.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics.